Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancerNicole Williams, Robert Wesolowski, Courtney Johnson et al.|Therapeutic Advances in Medical Oncology|2023Cited by 14